Assessing the Patient Experience in Cancer Care

Melanoma Clinical Trial

Official title:

Assessing the Patient Experience in Cancer Care: An Observational Communication Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01621295
• Other study ID #: 11-006682
• Secondary ID: R01AT006515
• Status: Completed
• Phase: N/A
• First received: June 14, 2012
• Last updated: January 18, 2016
• Start date: May 2012
• Est. completion date: September 2015

Study information

• Verified date: January 2016
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Communication is an important component of comprehensive cancer care impacting patient satisfaction, adherence, and quality of life. The wide array of issues addressed in cancer clinical interactions makes communicating about a broad range of topics (including quality of life, communication, symptom control, complementary/alternative therapies, costs, treatment burden, prognosis, anxiety, side-effects, sexual function, palliative care options, etc.) especially interesting and potentially challenging. Some of these topics may not be routinely addressed in the clinical interaction or may require consultative support from other members of the comprehensive cancer care team. One frequently overlooked critical element in research on communication between cancer clinicians, their patients, and their primary care clinicians is describing real-time consultations between patients and their clinicians. These interactions provide rich material for assessing key psycho-social dynamics and identifying issues that patients find important in their care. In order to devise systems of care that optimize the patient experience, it is critical that clinicians and researchers understand, appreciate, and systematically characterize the richness and complexity of the decision-making process in routine cancer consultations between cancer patients and their treating clinicians. This study seeks to assess the patient experience in cancer care by observing patients and their physicians in their clinical interactions and following them for several months to see how their care went. By describing in-depth the conversations and experiences of patients in these clinical interactions, this study will lay the foundation for practice-based interventions to optimize patients' interactions with their cancer care teams.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 408
• Est. completion date: September 2015
• Est. primary completion date: September 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age greater than or equal to 18 years

• Histological confirmation of: brain, breast, endocrine, gastrointestinal, genitourinary, gynecological, head/neck, lung, melanoma, or sarcoma malignancies.

• Speak English or Spanish

• Not enrolled in hospice

• In any of the following phases of the cancer control continuum: initial diagnosis, initial treatment, early survivorship, or recurrence.

• Provide written informed consent

Exclusion Criteria:

Study Design

N/A

Related Conditions & MeSH terms

• Brain Neoplasm
• Brain Neoplasms
• Breast Neoplasm
• Breast Neoplasms
• Digestive System Neoplasms
• Endocrine Gland Neoplasm
• Endocrine Gland Neoplasms
• Gastrointestinal Neoplasm
• Gastrointestinal Neoplasms
• Genitourinary Neoplasm
• Gynecological Neoplasm
• Head and Neck Neoplasm
• Head and Neck Neoplasms
• Lung Neoplasm
• Lung Neoplasms
• Melanoma
• Neoplasms
• Sarcoma
• Urogenital Neoplasms

Locations

Country	Name	City	State
United States	Los Angeles County Hospital	Los Angeles	California
United States	University of Southern California - Norris	Los Angeles	California
United States	Mayo Clinic	Rochester	Minnesota

Sponsors (4)

Lead Sponsor	Collaborator
Mayo Clinic	Johns Hopkins University, National Center for Complementary and Integrative Health (NCCIH), University of Southern California

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Frequency/duration/content of routine cancer consultations surrounding key topics in the clinical dialogue.	Key topics to be studied include: quality of life, complementary and alternative therapies, psycho-social characteristics, patient-clinician dynamics, health literacy	Time of enrollment through completion of 3 month follow-up survey	No